Microbiome diversity in the sputum of patients with pulmonary tuberculosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 7, 2016, Pages 1205-1210

  Krishna, P ^a   Jain, A ^a   Bisen, P S ^b  

^a Avantor Performance Materials India Limited (formerly RFCL Limited)   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ACINETOBACTER; ACTINOBACILLUS; ACTINOBACTERIA; ADULT; AGED; ARTICLE; ATOPOBIUM; BACILLUS; BACTEROIDETES; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; FIRMICUTES; FUSOBACTERIA; GAMMAPROTEOBACTERIA; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; HUMAN; INCIDENCE; INDIA; LACTOBACILLUS; LEUCONOSTOC; LUNG TUBERCULOSIS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; MOLLICUTES; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTHIA; SPECIES RICHNESS; SPIROCHETE; SPUTUM SMEAR; STREPTOCOCCUS; VEILLONELLA; BIODIVERSITY; CASE CONTROL STUDY; CLUSTER ANALYSIS; GENETICS; METAGENOME; METAGENOMICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; AGED; BIODIVERSITY; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; METAGENOME; METAGENOMICS; MICROBIOTA; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RNA, RIBOSOMAL, 16S; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84965066082     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2654-4     Document Type: Article

References (24)

1. WHO (2014) Global tuberculosis report 2014. World Health Organuisation, Geneva
2. Zhou Y, Lin P, Li Q, Han L, Zheng H, Wei Y, Cui Z, Ni Y, Guo X (2010) Analysis of the microbiota of sputum samples from patients with lower respiratory tract infections. Acta Biochim Biophys Sin Shanghai 42(10):754–761
3. Pedron T, Sansonetti P (2008) Commensals bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3:344–347
4. Bisen PS (2015) Potential of microbiome research in respiratory diseases. J Respir Res 1(1):13–14
5. Zacharia AJ, Jain A, Raghuvanshi R, Kumar A, Prasad GBKS, Bisen PS (2016) Gas chromatography and mass spectroscopy based detection of autoinducer-2 like molecule in the circulation of tuberculosis infected cases. J Respir Res 2(1):33–36
6. Blaser MJ, Falkow S (2009) What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7(12):887–894
7. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI et al (2009) Bacterial community variation in human body habitats across space and time. Science 326:1694–1697
8. The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
9. Ling Z, Kong J, Liu F, Zhu H, Chen X et al (2010) Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 11:488
10. Charlson ES, Bittinger K, Chen J, Diamond JM, Li H et al (2012) Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. Plos One 7, e42786
11. Lazarevic V, Whiteson K, Huse S, Hernandez D, Farinelli L et al (2009) Metagenomic study of the oral microbiota by Illumina high-throughput sequencing. J Microbiol Methods 79:266–271
12. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L et al (2011) Analysis of the lung microbiome in the “healthy” smoker and in COPD. Plos One 6, e16384
13. Cui Z, Zhou Y, Li H, Zhang Y, Zhang S et al (2012) Complex sputum microbial composition in patients with pulmonary tuberculosis. BMC Microbiol 12:276
14. Cheung MK, Lam WY, Fung WY, Law PT, Au CH et al (2013) Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. Plos One 8, e54574
15. Wu J, Liu W, He L, Huang F, Chen J, Cui P et al (2013) Sputum microbiota associated with new, recurrent and treatment failure tuberculosis. Plos One 8(12), e83445
16. Bhat J, Rao VG, Yadav R, Muniyandi M, Sharma R, Karfarma C, Luke C (2015) Situation of drug resistant tuberculosis in Saharia tribe of central India. Indian J Med Res 141(5):636–639
17. Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A et al (2012) Microbiome diversity in the bronchial tract of patients with chronic obstructive pulmonary disease. J Clin Microbiol 50:3562–3568
18. Coburn B, Wang PW, Diaz Caballero J, Clark ST, Brahma V et al (2015) Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep 5:10241
19. Fusconi M, Conti C, de Virgilio A, Vincentiis M (2009) Polmonite paucisintomatica da Rothia mucilaginosa: caso clinica e rassegna della letteratura. Infez Med 2:100–104
20. Baeza Martínez C, Zamora Molina L, García Sevila R, Gil Carbonell J, Ramos Rincon JM, Martín Serrano C (2014) Rothia mucilaginosa pneumonia in an immunocompetent patient. Arch Bronconeumol 50(11):493–495
21. Loughrey AC, Chew EW (1990) Endocarditis caused by Veillonella dispar. J Infect 21:319–321
22. Houston SD, Taylor D, Rennie R (1997) Prosthetic valve endocarditis due to Veillonella dispar: successful medical treatment following penicillin desensitization. Clin Infect Dis 24:1013–1014
23. Fisher K, Phillips C (2009) The ecology, epidemiology and virulence of Enterococcus. Microbiology 155:1749–1757
24. Parameswaran G, Wrona CT, Murphy TF, Sethi S (2009) Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect Dis 9:178